Recurrent culture-proven sepsis linked to retinopathy of prematurity in neonates: JAMA
A new study published in the Journal of American Medical Association suggests that repeated culture-proven sepsis should be recognized as a modifiable risk factor linked to retinopathy of prematurity in extremely preterm newborns.
Retinopathy of prematurity (ROP) is a significant morbidity associated with preterm newborns that results in visual impairment, including blindness. Prevention and prompt treatment are essential to combat this condition. There is mounting evidence that the development of ROP is facilitated by exposure to neonatal sepsis. In order to better understand the relationship between neonatal sepsis and ROP in two sizable cohorts of preterm children born at fewer than 29 weeks of gestation, Kirsten Glaser and colleagues undertook this study.
The data from the Norwegian Neonatal Network (NNN) and German Neonatal Network (GNN) were utilized in this retrospective cohort analysis. There were 68 level III neonatal critical care units in the GNN and 21 in the NNN. The newborns for this research were recruited in the GNN between January 1, 2009 and December 31, 2022, and the NNN between January 1, 2009 and December 31, 2018. They ranged in gestation from 22 weeks and 0 days to 28 weeks and 6 days. From February through September of 2023, the data obtained were examined.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.